Table 6.
Mature sizeb | Implantc | Pooled | |||||
---|---|---|---|---|---|---|---|
Item | SMS | LMS | P value | NI | SS | P value | SEM |
Backgrounding-phased | |||||||
n, steers | 80 | 79 | – | 80 | 79 | – | – |
n, pens | 10 | 10 | – | 10 | 10 | – | – |
Initial body weight, kg | 308 | 371 | <0.01 | 339 | 340 | 0.04 | 0.3 |
Interim body weight, kg | 436 | 503 | <0.01 | 466 | 474 | 0.01 | 1.7 |
Average daily gain, kg | 1.52 | 1.57 | 0.14 | 1.50 | 1.59 | 0.01 | 0.021 |
Dry matter intake, kg | 8.68 | 9.84 | <0.01 | 9.14 | 9.38 | 0.01 | 0.055 |
Dry matter intake/MBSe, g/kg | 102.4 | 103.0 | 0.49 | 101.8 | 103.7 | 0.03 | 0.53 |
Gain:feed | 0.175 | 0.160 | <0.01 | 0.165 | 0.170 | 0.08 | 0.0018 |
GEDf, Mcal/kg | 4.14 | 4.58 | <0.01 | 4.40 | 4.32 | 0.31 | 0.050 |
Finishing-phased | |||||||
n, steers | 79 | 79 | – | 80 | 78 | – | – |
n, pens | 10 | 10 | – | 10 | 10 | – | – |
Interim body weight, kg | 436 | 503 | <0.01 | 466 | 474 | 0.01 | 1.7 |
Final body weight, kg | 587 | 660 | <0.01 | 618 | 629 | <0.01 | 1.9 |
Average daily gain, kg | 1.79 | 1.87 | 0.01 | 1.81 | 1.84 | 0.24 | 0.018 |
Dry matter intake, kg | 11.41 | 12.68 | <0.01 | 11.82 | 12.27 | <0.01 | 0.044 |
Dry matter intake/MBSe, g/kg | 106.0 | 107.0 | 0.04 | 105.2 | 107.8 | <0.01 | 0.31 |
Gain:feed | 0.157 | 0.147 | <0.01 | 0.154 | 0.150 | 0.15 | 0.0015 |
GEDf, Mcal/kg | 5.89 | 6.29 | <0.01 | 5.99 | 6.19 | 0.05 | 0.064 |
aShrink (3%) was applied to all body weights.
bSMS, smaller mature size; LMS, larger mature size.
cNI, nonimplanted during backgrounding-phase, implanted with 24 mg estradiol and 120 mg trenbolone acetate on d 85; SS, implanted with 20 mg estradiol benzoate and 200 mg progesterone on d 2 and with 24 mg estradiol and 120 mg trenbolone acetate on d 85.
dBackgrounding-phase, d 1–84; Finishing-phase, d 85–168.
eMBS, metabolic body size, calculated as weight3/4 (Kleiber, 1961).
fGED, gain energy density, calculated as estimated retained energy divided by ADG.